SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-139453
Filing Date
2017-04-26
Accepted
2017-04-26 16:06:04
Documents
6
Period of Report
2017-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d386110d6k.htm 6-K 9765
2 EX-99.1 d386110dex991.htm EX-99.1 22650
3 EX-99.2 d386110dex992.htm EX-99.2 676899
4 GRAPHIC g386110g0426133545435.jpg GRAPHIC 3974
5 GRAPHIC g386110g0426133638784.jpg GRAPHIC 2945
6 GRAPHIC g386110g0426133639097.jpg GRAPHIC 16589
  Complete submission text file 0001193125-17-139453.txt   743138
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 17784375
SIC: 2834 Pharmaceutical Preparations